Sustained complete remission with third-line nivolumab in advanced renal cell carcinoma: a case report
This case exemplifies the long-term benefit of immunotherapy in advanced renal cell carcinoma, emphasizing the importance of vigilant monitoring for immune-related adverse events, sustained follow-up, and the potential for extended therapy-free remission.
Authors
- Lajos Géczi (ORCID: https://orcid.org/0009-0002-9538-0829)
- Zsófia Kürönya (ORCID: https://orcid.org/0000-0001-8500-5924)
- Enikő Lénárt
- Edina Soós
- Krisztina Biró
Institutions
- National Institute of Oncology (HU)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1186/s13256-026-05886-3
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 36.44